Member Info for Alwaysone

The heading here is a good sign I think, so sit it out a little more but great if you have found the bottom today. DYOR
https://www.ii.co.uk/analysis-commentary/why-genedrive-shares-are-3200-just-six-weeks-ii511547

BTW, I hate shorters, and wouldn't know where to start if I wanted to. I don't think HL thatI am with even let you do it.

Where's bigbench and scart? They normally have sound advice
I personally still wouldn't be trying to find the bottom here now, but good luck if you do and it moves up.

You won't be able to buy these at £1 in a million years aside from a big market drop IMHO, DYOR

I sold Monday and waiting for the price to find sold support, wherever that is. Don't mind losing 10% increase to find where that is

I am happy for everyone who bought at way below £1 that have top sliced and maybe left profits in, but do feel for the PIs that have bought in the last 3 days, terrible actions by the company, has left a real bad taste in my mouth.
That said, I keep an eye on AVCT, whohad that 18p share placing and they are still above a £1, so it's only a matter of time and price, when this starts moving back up from a solid support --- but where is that? My guess like yesterday is between £1.35 to £1.50, think more like £1.35

Don’t forget that NCYT started really motoring when just before they shipped stock and then widened distribution and bigger orders. Then WHO approved midway through, which helped push it again. Orders based primarily. We’re buying ahead of the expected huge orders due on many fronts but not at this current time as turnover low currently.

If only that was the true, but no

Was a long overview but lost the page so in brief this time!
AVCT raised funds at 18p early April and the share price hadn’t moved to nice at the time. It’s built to above £1 now.
GDR had massive increases in price and raised at 80p , after two big RNSs. Price had hit £3 for a short time
But at 80p it’s still more than 50% less than today’s price. So back to front to AVCT.
Many PIs, less so the ones who bought under £1, feel aggrieved, confused and less confident in management.
So one can’t be too surprised with the markets reaction, even if the cash is good for the company’s growth. The share price will eventually be a lot higher I’m sure, subject to markets not diving. But short term without an RNS, I fear the price will drift. No idea where to. If I had to guess, I’d say £1.30/£1.50 but what do I know!

I guessed 15% this morning, but probably 25%. Poor peeps that bought at £2.50 plus yesterday.

The old catch phrases .
Like catching a falling knife.
What goes up fast can drop as fast

We were looking at £3 yesterday morning, what a difference a day ( placing) makes ho hum
The director's and instutionss are all fine though plus all those PIs that bought in at below 50p

AVCT also down

What a **** day. bl00dy placing .........no idea where the level down is on this now

totally agree EthioEthio, it was terribly badly handled by the company, it actually didn't feel right ethically. Real shame a thought well of the bods before now

Small spike up coming, let's see if it can hold

It actually look seems we could slip 15% down, the market really isn't keen on that 80p placing after all the rises

sitting beside me lol

it's a stop loss MM shake out IMHO, ask price still holding fairly firm, price will go up

Whys are MMs angry They make money on all the trade margins?

bigbench, how do you see all the MMs?

3 mm's sitting @ 206-210 if you want in now is the time id say

The placing RNS was the cause of the huge drop until people realised what it all meant through the day and comparing to placings like AVCT at 18p. Do you think everyone is really that stupid. Panic set in as some people even thought the price would go to 80p. I read some of them.

This could be one reason for the excitement: In a note on Friday, analysts at Peel Hunt said the company’s test “fundamentally differentiates”; the company from others developing coronavirus tests and “perhaps places it as the only such provider of such a simple-step process – in this urgent global requirement”. And this could be another: The Genedrive(R) HCV-ID kit allows for decentralised molecular testing of HCV by PCR, providing results within 90 minutes direct from a small plasma sample (25ul). This allows for testing to be done outside of a large hospital facility and indeed while a patient may be waiting for a result. The assay is performed on the Genedrive(R) platform, the only truly portable molecular diagnostics system designed for diagnosing HCV at the point of need. And this could be a third: AVCT Market Cap £241 million NCYT Market Cap £234 million GDR Market Cap £74 million